• Cardio Conferences
  • Cardio Quick Review
  • Cardio Calendar
  • Cardio Articles
  • Cardio Refresher
  • Cardio Case
  • Cardio Talks
  • Cardio ECG
  • Symposium
    Umbrella Heart FailureSymposium 1401Umbrella HypertensionUmbrella, Heart And StrokeUmbrella, CCSSymposium 1400
  • Familial hypercholesterolemia, a narrative review, part 3: management

    July 9, 2022

    FH 3: management

  • Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening

    March 11, 2022

    FH 1: diagnosis and screening

  • HeartCast 5: practical approach to the treatment of HFrEF

    February 23, 2022

    The fifth HeartCast: HFrEF management

  • HeartCast 4: practical approach to the treatment of HFrEF

    February 9, 2022

    The fourth HeartCast: HFrEF management

  • Familial hypercholesterolemia, a narrative review, part 1: definition and burden

    January 14, 2022

    FH 1: Definition and burden

  • HeartCast 3: practical approach to the treatment of HFrEF

    January 11, 2022

    The third HeartCast: HFrEF management

  • At a Glance: Approach to Ticagrelor-induced Dyspnea

    January 2, 2022

    Managing dyspnea induced by Ticagrelor

  • HeartCast 2: practical approach to the treatment of HFrEF

    December 29, 2021

    The second HeartCast: HFrEF management

  • At a glance: preventing cardiovascular thrombotic event after ACS

    December 21, 2021

    Ticagrelor in preventing post-ACS thrombotic events

  • HeartCast 1: practical approach to the treatment of HFrEF

    December 15, 2021

    The first HeartCast: HFrEF management

  • Cardiopoint 13: Management of stage 1 hypertension in adults with low cardiovascular risk

    September 25, 2021

    Stage 1 HTN in low risk patients

  • Cardiopoint 12: Two-Drug Combinations as First-Step Antihypertensive treatment

    May 30, 2021

    Initial administration of two-drug combinations in HTN

  • Self-measured blood pressure monitoring at home

    April 17, 2021

    What to teach the patients about recording their blood pressure themselves

  • Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines

    April 7, 2021

    Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients

  • Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline

    April 6, 2021

    Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients

  • CardioPoint (11)

    CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI

    March 11, 2021

    Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management

  • CardioPoint (10)

    CardioPoint (10): The growing burden of cardiovascular diseases

    February 2, 2021

    Emphasizing the importance of CVD prevention and management

  • What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation

    December 7, 2020

    Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences

  • What is new in the 2020 ESC Guideline for the diagnosis and management of AF

    December 3, 2020

    Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs

  • Apixaban Hub (4)

    November 27, 2020

    NOAC Choice

  • What is new in the 2020 ESC Guideline for the diagnosis and management of AF

    November 3, 2020

    Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS

  • At a glance; Place of FDC in CV outcomes

    October 7, 2020

    Single-Pill Combination Therapy and CV Outcomes in HTN

  • What is new in the 2020 ESC Guideline for the diagnosis and management of AF

    October 3, 2020

    Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)

  • Apixaban in Clinical Practice

    Apixaban Hub (3)

    September 23, 2020

    Apixaban in Clinical Practice

  • CardioPoint9

    CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations

    August 22, 2020

    A Brief Description on Practical Points in Anticoagulation

  • At a glance; FDC role in HTN Pharmacotherapy

    August 9, 2020

    Fixed dose combination therapy in HTN Treatment

  • Guideline Made Easy

    August 3, 2020

    Practical Guide for treatment of high blood cholesterol Part One

  • Apixaban Hub (2)

    July 27, 2020

    Apixaban in the pipeline: landmark clinical trials

  • Apixaban Hub (1)

    Apixaban Hub (1)

    June 27, 2020

    When to use, when not to use & which dose?

  • At a glance; How dual pathway found its way into ESC guidelines?

    June 7, 2020

    Rivaroxaban on board for CCS

  • CardioPoint8

    CardioPoint (8): When to consider drug treatment in hypertension?

    May 24, 2020

    A Brief Description on Practical Points in Cardiometabolic Field

  • Cardiac involvement in COVID-19 infection

    May 3, 2020

    Cardiovascular complications of COVID-19

  • At a glance: ACEI and ARB in COVID-19 Era

    March 19, 2020

    The challenge of to use or not to use ACEI/ARBs in patients with COVID-19

  • CardioPoint7

    CardioPoint (7): Selecting appropriate NOAC

    February 28, 2020

    A Brief Description on Practical Points in Anticoagulation

  • PCSK9 Inhibition from bench to bedside

    February 3, 2020

    Part Four: The Lower, The Better

  • PCSK9 Inhibition from bench to bedside

    January 3, 2020

    Part Three: PCSK9 Inhibitor in my practice

  • Guideline Made Easy

    December 7, 2019

    Practical Guide for Treatment of High Blood Pressure (Part Three)

  • Guideline Made Easy

    December 7, 2019

    Practical Guide for Treatment of High Blood Pressure (Part Two)

  • Guideline Made Easy

    December 7, 2019

    Practical Guide for Treatment of High Blood Pressure (Part One)

  • PCSK9 Inhibition from bench to bedside

    December 3, 2019

    Part Two: Clinical Trials

  • CardioPoint6

    CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol

    November 29, 2019

    A Brief Description on Practical Points in Cardiometabolic Field

  • Guideline Made Easy

    November 3, 2019

    Practical Guide for treatment of high blood cholesterol Part Three

  • PCSK9 Inhibition from bench to bedside

    November 3, 2019

    Part One: A success story

  • CardioPoint5

    CardioPoint (5): NOACs in CKD

    October 23, 2019

    A Brief Description on Practical Points in Anticoagulation

  • Guideline Made Easy

    October 3, 2019

    Practical Guide for treatment of high blood cholesterol Part Two

  • CardioPoint4

    CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension

    September 20, 2019

    A Brief Description on Practical Points in Cardiometabolic Field

  • CardioPoint (3)

    CardioPoint (3): NOACs in Elderly

    August 19, 2019

    A Brief Description on Practical Points in Anticoagulation

  • CardioPoint (2)

    CardioPoint (2) – NOAC Monitoring, Do NOACs Need Monitoring?

    June 19, 2019

    A Brief Description on Practical Points in Anticoagulation

  • CardioPoint 1

    CardioPoint (1):Statins-Who is eligible?-Which dose?

    May 19, 2019

    A Brief Description on Practical Points in Cardiometabolic Field

Follow US
  • admin@dailycardiology.ir
  • Telegram
  • Instagram
  • Contact us
  • Become a team member
Clinical Topics
    • Acute Coronary Syndrome
    • Ambulatory Blood Pressure Monitoring
    • Anticoagulation
    • Arrhythmia
    • Atrial Fibrillation
    • Cardiac Catheterization
    • Cardiac Imaging
    • Cardiac Surgery
    • Cardiometabolic Disease
    • Congenital Heart Disease
Clinical Topics
    • Coronary Angiography and Intervention
    • Deep Vein Thrombosis
    • Echocardiography
    • Electrocardiography
    • Geriatric Cardiology
    • Heart Failure
    • Hypertension
    • Infective Endocarditis
    • Noncoronary Invasive Procedures
    • Peripheral Arterial Disease
Clinical Topics
    • Pharmacotherapy
    • Prevention
    • Pulmonary Embolism
    • Pulmonary Hypertension
    • Sports and Exercise Cardiology
    • Stable ischemic Heart Disease
    • Valvular Heart Disease
    • COVID-19
    • CVD and disorders of other organs
    • Noncardiac Surgery

Copyright All rights reserved ©2021 Daily Cardiology Academy Team

Design By Tysiz